These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 15800937

  • 21. Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients.
    Stern MB, Marek KL, Friedman J, Hauser RA, LeWitt PA, Tarsy D, Olanow CW.
    Mov Disord; 2004 Aug; 19(8):916-23. PubMed ID: 15300656
    [Abstract] [Full Text] [Related]

  • 22. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA, Brecher M, Paulsson B.
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [Abstract] [Full Text] [Related]

  • 23. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS, Konarski JZ, Jones M, Paulsson B.
    J Affect Disord; 2007 Oct; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [Abstract] [Full Text] [Related]

  • 24. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
    Vieta E, Goldberg JF, Mullen J, Vågerö M, Paulsson B.
    J Affect Disord; 2007 Oct; 100 Suppl 1():S23-31. PubMed ID: 17382403
    [Abstract] [Full Text] [Related]

  • 25. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN, Vieta E, Young AH, Möller HJ, Paulsson B, Vågerö M.
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [Abstract] [Full Text] [Related]

  • 26. Olanzapine treatment for dopaminergic-induced hallucinations.
    Ondo WG, Levy JK, Vuong KD, Hunter C, Jankovic J.
    Mov Disord; 2002 Sep; 17(5):1031-5. PubMed ID: 12360554
    [Abstract] [Full Text] [Related]

  • 27. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis.
    Merims D, Balas M, Peretz C, Shabtai H, Giladi N.
    Clin Neuropharmacol; 2006 Sep; 29(6):331-7. PubMed ID: 17095896
    [Abstract] [Full Text] [Related]

  • 28. [Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease].
    Giménez-Roldán S, Navarro E, Mateo D.
    Rev Neurol; 2006 Sep; 36(5):401-4. PubMed ID: 12640589
    [Abstract] [Full Text] [Related]

  • 29. Twice-daily, low-dose pramipexole in early Parkinson's disease: a randomized, placebo-controlled trial.
    Kieburtz K, Parkinson Study Group PramiBID Investigators.
    Mov Disord; 2011 Jan; 26(1):37-44. PubMed ID: 20925067
    [Abstract] [Full Text] [Related]

  • 30. Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's disease.
    Morgante L, Epifanio A, Spina E, Di Rosa AE, Zappia M, Basile G, La Spina P, Quattrone A.
    Neurol Sci; 2002 Sep; 23 Suppl 2():S89-90. PubMed ID: 12548358
    [Abstract] [Full Text] [Related]

  • 31. Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease.
    Fernandez HH, Trieschmann ME, Okun MS.
    Mov Disord; 2005 Jan; 20(1):104-5. PubMed ID: 15390047
    [Abstract] [Full Text] [Related]

  • 32. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF, Paulsson B, Brecher M.
    J Affect Disord; 2007 Jan; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [Abstract] [Full Text] [Related]

  • 33. Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial.
    McIntyre RS, Brecher M, Paulsson B, Huizar K, Mullen J.
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):573-85. PubMed ID: 16139175
    [Abstract] [Full Text] [Related]

  • 34. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease.
    Hauser RA, Lyons KE, McClain T, Carter S, Perlmutter D.
    Mov Disord; 2009 May 15; 24(7):979-83. PubMed ID: 19230029
    [Abstract] [Full Text] [Related]

  • 35. A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease.
    Stacy M, Silver D, Mendis T, Sutton J, Mori A, Chaikin P, Sussman NM.
    Neurology; 2008 Jun 03; 70(23):2233-40. PubMed ID: 18519872
    [Abstract] [Full Text] [Related]

  • 36. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.
    Bipolar Disord; 2009 Aug 03; 11(5):483-93. PubMed ID: 19624387
    [Abstract] [Full Text] [Related]

  • 37. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
    Berger GE, Proffitt TM, McConchie M, Kerr M, Markulev C, Yuen HP, O'Donnell C, Lubman D, Polari A, Wood S, Amminger PG, McGorry PD.
    J Clin Psychiatry; 2008 Nov 03; 69(11):1702-14. PubMed ID: 19036233
    [Abstract] [Full Text] [Related]

  • 38. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
    Leentjens AF, Koester J, Fruh B, Shephard DT, Barone P, Houben JJ.
    Clin Ther; 2009 Jan 03; 31(1):89-98. PubMed ID: 19243709
    [Abstract] [Full Text] [Related]

  • 39. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects.
    Datto C, Berggren L, Patel JB, Eriksson H.
    Clin Ther; 2009 Mar 03; 31(3):492-502. PubMed ID: 19393840
    [Abstract] [Full Text] [Related]

  • 40. Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study.
    Vaishnavi S, Alamy S, Zhang W, Connor KM, Davidson JR.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1464-9. PubMed ID: 17698275
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.